4//SEC Filing
Drachman David J 4
Accession 0001181431-12-029264
CIK 0001323885other
Filed
May 9, 8:00 PM ET
Accepted
May 10, 9:17 PM ET
Size
21.9 KB
Accession
0001181431-12-029264
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Drachman David J
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2012-05-08$9.10/sh−18,575$169,033→ 405,106 total - Exercise/Conversion
Common Stock
2012-05-08$1.33/sh+18,575$24,705→ 423,681 total - Exercise/Conversion
Common Stock
2012-05-10$1.33/sh+87,160$115,923→ 492,266 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-09−2,900→ 118,642 totalExercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (2,900 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-10−1,586→ 117,056 totalExercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (1,586 underlying) - Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-10−87,160→ 29,896 totalExercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (87,160 underlying) - Exercise/Conversion
Common Stock
2012-05-09$1.33/sh+2,900$3,857→ 408,006 total - Exercise/Conversion
Common Stock
2012-05-10$1.33/sh+1,586$2,109→ 406,692 total - Sale
Common Stock
2012-05-10$9.04/sh−1,586$14,337→ 405,106 total - Sale
Common Stock
2012-05-09$9.06/sh−2,900$26,274→ 405,106 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2012-05-08−18,575→ 121,542 totalExercise: $1.33From: 2003-10-14Exp: 2012-10-14→ Common Stock (18,575 underlying)
Footnotes (3)
- [F1]This transaction was executed in multiple trades at prices ranging from $9.06 to $9.12 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $9.01 to $9.05 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]These options were granted on October 14, 2002 and are exercisable cumulatively at a rate of 25% per annum beginning on October 14, 2003 (one year from grant date).
Documents
Issuer
AtriCure, Inc.
CIK 0001323885
Entity typeother
Related Parties
1- filerCIK 0001336087
Filing Metadata
- Form type
- 4
- Filed
- May 9, 8:00 PM ET
- Accepted
- May 10, 9:17 PM ET
- Size
- 21.9 KB